Be sure to check out the Dynaverse.Net Repository, the most comprehensive SFC library around !! ftp.dynaverse.net
0 Members and 1 Guest are viewing this topic.
Cytos Biotechnology of Zurich, Switzerland, has developed a drug that it calls CYT003-QbG10, which fools the body into thinking it is being attacked by mycobacteria. This class of bacteria is encountered far less today because of modern cleanliness. The bogus attack tricks the immune system into changing tactics to focus on tackling the potentially larger threat, rather than producing allergic reactions to less harmful things.Preliminary results from a trial of 10 people with hay fever suggest that after a six-week course of injections, their sensitivity to grass pollen was reduced a hundredfold, eliminating their symptoms. Cytos claims the patients remained symptom-free up to eight months after the therapy, though it could not say whether the relief would be permanent.